The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase 1/2 trial evaluating TAC01-CLDN18.2 autologous T cells in CLDN18.2-positive solid tumors.
 
Ecaterina Elena Dumbrava
Consulting or Advisory Role - Bolt Biotherapeutics; Mersana; Orum Therapeutics; Summit Therapeutics
Speakers' Bureau - PMV Pharma
Research Funding - Aileron Therapeutics; Amgen; Aprea Therapeutics; Bayer; Bellicum Pharmaceuticals; Boehringer Ingelheim; Bolt Biotherapeutics; Compugen; Dragonfly Therapeutics; Genentech; Gilead Sciences; Immunocore; Mereo BioPharma 5; Mersana; PMV Pharma; Poseida Therapeutics; Sanofi; Seagen; Sotio; TRACON Pharma; Triumvira Immunologics, Inc; Unum Therapeutics
Travel, Accommodations, Expenses - ASCO; Banner MD Anderson Cancer Center; Li-Fraumeni Syndrome Association; Rain Oncology; Triumvira Immunologics, Inc
 
Davendra Sohal
Honoraria - Foundation Medicine
Consulting or Advisory Role - AADi; Ability Pharma; AstraZeneca/MedImmune; Bayer; Elevar Therapeutics; Totus Medicines; TransThera Sciences (Nanjing), Inc.; Valar Labs
Speakers' Bureau - AstraZeneca; Genentech; Incyte; Seagen
Research Funding - Ability Pharma (Inst); Amgen (Inst); Apexigen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bexion (Inst); Bristol-Myers Squibb (Inst); FibroGen (Inst); Genentech (Inst); Hengrui Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); NextCure (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Triumvira Immunologics, Inc (Inst)
Travel, Accommodations, Expenses - Ability Pharma
 
Daniel Olson
Consulting or Advisory Role - Gerson Lehrman Group; Iovance Biotherapeutics; MJH Life Sciences; Novartis; Novartis
 
Samuel Saibil
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Immunocore; Janssen; Novartis; Sanofi
Travel, Accommodations, Expenses - Iovance Biotherapeutics
 
Alejandro Urgelles
Employment - CARsgen Therapeutics; Triumvira Immunologics, Inc
Travel, Accommodations, Expenses - CARsgen Therapeutics; Triumvira Immunologics, Inc
 
Maria Apostolopoulou
Employment - Triumvira Immunologics, Inc
Patents, Royalties, Other Intellectual Property - Wang X, Apostolopoulou M, Wetherby K (filed 03/21/2019) Apparatus and method for collecting multi-tiered particles from a biological sample. U.S. Provisional Pat. Ser. No. 62/821,598
 
Amy Mueller
Employment - Myovant Sciences; Tempus
 
Kara M. Moss
Employment - Triumvira Immunologics, Inc
Stock and Other Ownership Interests - Triumvira Immunologics, Inc
Travel, Accommodations, Expenses - Triumvira Immunologics, Inc
 
Deyaa R Adib
Employment - Triumvira Immunologics, Inc
Leadership - Triumvira Immunologics, Inc
Stock and Other Ownership Interests - Triumvira Immunologics, Inc
Consulting or Advisory Role - Eagle Pharmaceuticals; Epizyme; Ikena Oncology; Mythic Therapeutics; OBI Pharma; RAIN
Research Funding - Eagle Pharmaceuticals; Epizyme; Ikena Oncology; Mythic Therapeutics; OBI Pharma; RAIN
Travel, Accommodations, Expenses - Eagle Pharmaceuticals; Epizyme; Ikena Oncology; Mythic Therapeutics; OBI Pharma; RAIN
 
Benjamin L. Schlechter
Honoraria - Quercegen Pharmaceuticals
 
Syma Iqbal
Honoraria - BeiGene
Consulting or Advisory Role - AstraZeneca; BMS; BMS; Daiichi Sankyo/Astra Zeneca; Merck